spacer
The Healthcare Sales & Marketing Network celebrates 26 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Microcyn 

 HSMN NewsFeed - 16 Mar 2017
Sonoma Pharmaceuticals Announces Results from SebuDerm(TM) Gel Study in Treatment of Seborrheic Dermatitis
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 31 Jan 2017
Sonoma Pharmaceuticals Appoints Marc Umscheid as Chief Strategy and Marketing Officer
Biopharmaceuticals Dermatology Personnel
 HSMN NewsFeed - 30 Aug 2016
Oculus Innovative Sciences Launches Lasercyn(TM) into U.S. Dermatology Market for Use Following Laser Procedures, Microdermabrasions and Chemical Peels
Biopharmaceuticals Dermatology Product Launch
 HSMN NewsFeed - 20 Apr 2016
Oculus Innovative Sciences Receives U.S. FDA Approval for Lasercyn(TM) for Use Following Laser Procedures, Microdermabrasions and Chemical Peels
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 13 Apr 2016
Oculus Innovative Sciences Receives European Approval to Market Sinudox(TM) Indicated for Use in Nasal Irrigation
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 30 Mar 2016
Oculus Innovative Sciences and Lipogrid of Sweden Announce Strategic Collaboration for Topical Dermatology Drug Delivery
Biopharmaceuticals Drug Delivery Dermatology
 HSMN NewsFeed - 3 Mar 2016
Oculus Innovative Sciences Receives European Approval to Market Lasercyn Indicated for Use Following Laser Skin Resurfacing
Biopharmaceuticals Dermatology Regulatory
 HSMN NewsFeed - 14 Jan 2016
Oculus Innovative Sciences Receives European CE Mark for New MucoClyns(TM) for First Responders
Biopharmaceuticals Dermatology Regulatory
 HSMN NewsFeed - 17 Dec 2015
Oculus Innovative Sciences Receives FDA Clearance for Microcyn(R)-Based SebDerm Gel
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 4 Nov 2014
Oculus Innovative Sciences Receives European CE Mark for New Microcyn(R)-Based Scar Management Hydrogel
Devices Wound Care Dermatology Regulatory
 HSMN NewsFeed - 27 Mar 2014
Oculus Innovative Sciences Announces Appointment of Sharon Barbari to Its Board of Directors
Devices Wound Care Personnel
 HSMN NewsFeed - 27 Feb 2014
Oculus Innovative Sciences Announces Appointment of Russell Harrison to Board of Directors
Devices Wound Care Personnel
 HSMN NewsFeed - 4 Feb 2014
Oculus Innovative Sciences Receives European CE Mark for Use of Microcyn(R) in the Topical Treatment of Mild to Moderate Acne
Devices Dermatology Regulatory
 HSMN NewsFeed - 7 Jan 2014
Oculus Innovative Sciences Introduces Two New Microcyn(R) Advanced Wound Care Products for U.S. Prescription Wound Care Market
Devices Wound Care Product Launch
 HSMN NewsFeed - 8 Feb 2011
Oculus Innovative Sciences Receives New FDA 510(k) Clearance for Microcyn-Based Dermatology HydroGel for Management of Atopic Dermatitis, Radiation Dermatitis and Other Skin Dermatoses
Devices Dermatology FDA
 HSMN NewsFeed - 2 Jun 2010
Oculus Innovative Sciences Launches Microcyn(R) Negative-Pressure Wound Therapy Solution for U.S. Market
Devices Wound Care
 HSMN NewsFeed - 10 Mar 2010
Oculus Innovative Sciences Receives First FDA Clearance for Microcyn®-Based HydroGel for Dermatology Market with Claims Including Reduction of Itch and Pain Relief
Devices Wound Care Dermatology FDA
 HSMN NewsFeed - 16 Sep 2009
Oculus Innovative Sciences Announces New Partnership Agreement with V&M Industries, Inc. for Microcyn(R)-Based OTC Human Wound Care Products
Biopharmaceuticals Wound Care
 HSMN NewsFeed - 10 Sep 2009
Oculus Innovative Sciences Receives Medicare HCPCS Code for Reimbursement of Microcyn(R) Skin & Wound HydroGel
Biopharmaceuticals Wound Care Reimbursement
 HSMN NewsFeed - 27 May 2009
Oculus Innovative Sciences Receives FDA Clearance for Microcyn Skin and Wound Gel
Biopharmaceuticals Wound Care FDA
 HSMN NewsFeed - 22 Oct 2008
Oculus Innovative Sciences Launches Microcyn(R) Wound Care for U.S. Podiatry Market
Devices Wound Care
 HSMN NewsFeed - 23 Apr 2008
Oculus Innovative Sciences Appoints Michelle Carpenter, JD, RAC, as Vice President of Regulatory Affairs and Quality
Biopharmaceuticals Wound Care Personnel
 HSMN NewsFeed - 17 Mar 2008
Oculus Innovative Sciences Announces Positive Results From Three Abstracts Evaluating the Use of Microcyn(R) Technology in Diabetic Foot Ulcers
Biopharmaceuticals Wound Care
 HSMN NewsFeed - 27 Feb 2008
Oculus Innovative Sciences Announces Positive Top-Line Phase II Data with Microcyn(R) Technology in Mildly Infected Diabetic Foot Ulcers
Biopharmaceuticals Wound Care
 HSMN NewsFeed - 17 Jan 2008
Oculus Innovative Sciences, Inc. Appoints Gregg Alton to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Jan 2008
Oculus Innovative Sciences Completes Patient Treatment and Follow-up in Its Phase II Clinical Trial in Mildly Infected Diabetic Foot Ulcers
Biopharmaceuticals Wound Care
 HSMN NewsFeed - 18 Dec 2007
Oculus Innovative Sciences Announces Completion of Two Randomized Controlled Clinical Trials of Microcyn(R) Technology in China
Biopharmaceuticals Wound Care
 HSMN NewsFeed - 19 Nov 2007
Oculus Innovative Sciences Wins Federal Court Ruling in Intellectual Property Rights Litigation
Biopharmaceuticals Litigation
 HSMN NewsFeed - 17 Sep 2007
Oculus Innovative Sciences Provides Update of Phase II Study for Microcyn(R) Technology in Mildly Infected Diabetic Foot Ulcers
Biopharmaceuticals Wound Care
 HSMN NewsFeed - 18 Jun 2007
Oculus Innovative Sciences Appoints Vice President of Regulatory Affairs and Quality
Biopharmaceuticals Personnel
Return to NewsFeed  

 Additional items found! 4

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 4 additional stories matching:
Microcyn
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.